• Female patients with histologically confirmed primary breast cancer, stage I-III after lumpectomy or mastectomy scheduled for adjuvant radiotherapy at the University of Heidelberg Medical Center
|
• Acute infectious disease
|
• Inability to walk or stand
|
• Severe neurological deficiencies
|
• Age ≥18 years of age
|
• Severe cardiac or cardiovascular disease
|
• BMI ≥18 kg/m2
|
• Severe respiratory insufficiency
|
• Ability to understand and follow the study protocol
|
• Severe renal failure
|
• Willingness to come to the Heidelberg exercise facilities and adhere to study protocol
|
• Other concurrent malignant disease (except carcinoma in situ of skin or cervix)
|
• Written informed consent |
• Substance abuse (potentially leading to non-compliance)
|
• Participation in systematic intense resistance or aerobic training (at least 1 h twice per week)
|
• Previous participation in another exercise intervention trial |